PPL vs VYNE · P/E 22, rev $9.04B vs rev $501.0K
PPL Corporation (PPL) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported PPL revenue for 2025-12-31 was $9.04B. Net income was $1.18B. Revenue was up 6.9% from 2024-12-31 to 2025-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
PPL currently screens at market cap $26.58B and trailing P/E 21.7. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the PPL and VYNE stock pages for the full models.
Not investment advice.